Dramatic Enhancement of Binding Affinities Between Foldamer-Based Receptors and Anions by Intra-Receptor π-Stacking
Sung Beom Seo1, Seungwon Lee1, Hae-Geun Jeon1
1Department of Chemistry, Yonsei University, Seoul, 03722, Republic of Korea.
Angewandte Chemie (International Ed. in English)
|March 12, 2020
Summary
Researchers explored how protein folding and binding influence molecular interactions. They found that specific structural features in synthetic receptors significantly boosted binding affinities for ions like chloride and nitrate.
Area of Science:
- Supramolecular Chemistry
- Chemical Biology
- Organic Chemistry
Background:
- Understanding intra-protein interactions is crucial for designing effective molecular binders.
- Foldamer-based receptors offer a synthetic platform to study binding and folding dynamics.
- Aryl appendages can influence receptor structure and ligand binding through non-covalent interactions.
Purpose of the Study:
- To investigate the energetic interplay between binding and folding in synthetic receptors.
- To design foldamer-based receptors with tunable π-stacking interactions for enhanced anion binding.
- To elucidate the role of aryl appendages in stabilizing helical structures and reinforcing binding affinities.
Main Methods:
- Design and synthesis of foldamer-based receptors with identical hydrogen-bonding sites and varied aryl appendages.
- Utilizing π-stacking interactions within helical backbones for structural stabilization.
- Quantifying binding affinities using association constants for chloride and nitrate ions.
Main Results:
- Receptors with electron-deficient aryl appendages demonstrated significantly enhanced binding affinities.
- Association constants increased by up to three orders of magnitude for chloride and nitrate ions.
- Extended π-stacking interactions within the receptor backbone stabilized the overall complex structure.
Conclusions:
- The energetic interplay of binding and folding is a key factor in molecular recognition.
- Strategic design of aryl appendages in foldamer receptors can dramatically enhance anion binding.
- Stabilization of the folded structure through extended π-stacking is critical for reinforcing binding affinities.
More Related Videos
Related Concept Videos
Cooperative Allosteric Transitions
8.6K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.6K
Cooperative Allosteric Transitions
2.6K
2.6K
The Two-State Receptor Model
2.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.9K
Ligand Binding Sites
14.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.8K
Ligand Binding and Linkage
5.4K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.4K
Drug-Receptor Bonds
4.1K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
4.1K


